These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 23669167)

  • 41. Aminograms during continuous hemodiafiltration in the treatment of hyperammonemia due to ornithine transcarbamylase deficiency.
    Chen CY; Tsai TC; Lee WJ; Chen HC
    Ren Fail; 2007; 29(6):661-5. PubMed ID: 17763159
    [TBL] [Abstract][Full Text] [Related]  

  • 42. RC--a case of ornithine transcarbamylase (OTC) deficiency. The most commonly genetically acquired urea cycle defect.
    Morra DR; Nadkarni VM; Bartoshesky LE; Finkelstein MS
    Del Med J; 2000 Aug; 72(8):349-54. PubMed ID: 10984978
    [No Abstract]   [Full Text] [Related]  

  • 43. Maternal ornithine transcarbamylase deficiency, a genetic condition associated with high maternal and neonatal mortality every clinician should know: A systematic review.
    Torkzaban M; Haddad A; Baxter JK; Berghella V; Gahl WA; Al-Kouatly HB
    Am J Med Genet A; 2019 Oct; 179(10):2091-2100. PubMed ID: 31441224
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The dibasic amino acid metabolic disorders].
    Shimizu H
    Nihon Rinsho; 1992 Jul; 50(7):1555-60. PubMed ID: 1404883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Heterozygote ornithine transcarbamylase deficiency presenting as symptomatic hyperammonemia during initiation of valproate therapy.
    Honeycutt D; Callahan K; Rutledge L; Evans B
    Neurology; 1992 Mar; 42(3 Pt 1):666-8. PubMed ID: 1549234
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Congenital hyperammonemia: symptomatic carrier girl patient and her asymptomatic heterozygous mother for ornithine transcarbamylase (OTC) deficiency: specific enzyme diagnostic and kinetic investigations for the detection of heterozygous genostatus.
    László A; Karsai T; Várkonyi A
    Acta Paediatr Hung; 1991; 31(3):291-7. PubMed ID: 1742044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hyperammonemia type II as an example of urea cycle disorder].
    Hawrot-Kawecka AM; Kawecki GP; Duława J
    Wiad Lek; 2006; 59(7-8):512-5. PubMed ID: 17209350
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk of serious illness in heterozygotes for ornithine transcarbamylase deficiency.
    Batshaw ML; Msall M; Beaudet AL; Trojak J
    J Pediatr; 1986 Feb; 108(2):236-41. PubMed ID: 3944708
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hyperammonemia due to ornithine transcarbamylase deficiency--a cause of lethal metabolic crisis during the newborn period and infancy (author's transl)].
    Schuchmann L; Colombo JP; Fischer H
    Klin Padiatr; 1980 May; 192(3):281-5. PubMed ID: 7191930
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anesthetic implications of ornithine transcarbamylase deficiency.
    Dutoit AP; Flick RR; Sprung J; Babovic-Vuksanovic D; Weingarten TN
    Paediatr Anaesth; 2010 Jul; 20(7):666-73. PubMed ID: 20497355
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phenylbutyrate improves nitrogen disposal via an alternative pathway without eliciting an increase in protein breakdown and catabolism in control and ornithine transcarbamylase-deficient patients.
    Marini JC; Lanpher BC; Scaglia F; O'Brien WE; Sun Q; Garlick PJ; Jahoor F; Lee B
    Am J Clin Nutr; 2011 Jun; 93(6):1248-54. PubMed ID: 21490144
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical and laboratory screening studies on urea cycle defects].
    Yang YL; Sun F; Qian N; Song JQ; Wang S; Chang XZ; Yang HY; Wang SQ; Li L; Zhang YH; Bao XH; Li M; Qi Y; Qin J; Wu XR
    Zhonghua Er Ke Za Zhi; 2005 May; 43(5):331-4. PubMed ID: 15924745
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapy of urea cycle enzymopathies: three case studies.
    Batshaw ML; Painter MJ; Sproul GT; Schafer IA; Thomas GH; Brusilow S
    Johns Hopkins Med J; 1981 Jan; 148(1):34-40. PubMed ID: 7453005
    [No Abstract]   [Full Text] [Related]  

  • 54. Cerebral dysfunction in asymptomatic carriers of ornithine transcarbamylase deficiency.
    Batshaw ML; Roan Y; Jung AL; Rosenberg LA; Brusilow SW
    N Engl J Med; 1980 Feb; 302(9):482-5. PubMed ID: 7351973
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impairment of cognitive function in ornithine transcarbamylase deficiency is global rather than domain-specific and is associated with disease onset, sex, maximum ammonium, and number of hyperammonemic events.
    Buerger C; Garbade SF; Dietrich Alber F; Waisbren SE; McCarter R; Kölker S; Burgard P;
    J Inherit Metab Dis; 2019 Mar; 42(2):243-253. PubMed ID: 30671983
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical course of 63 patients with neonatal onset urea cycle disorders in the years 2001-2013.
    Unsinn C; Das A; Valayannopoulos V; Thimm E; Beblo S; Burlina A; Konstantopoulou V; Mayorandan S; de Lonlay P; Rennecke J; Derbinski J; Hoffmann GF; Häberle J
    Orphanet J Rare Dis; 2016 Aug; 11(1):116. PubMed ID: 27538463
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Attempted dietary treatment of a boy with hyperammonemia due to ornithine transferase deficiency.
    van der Heiden C; Bakker HD; Desplanque J; Brink M; de Bree PK; Wadman SK
    Eur J Pediatr; 1978 Jul; 128(4):261-72. PubMed ID: 668733
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients.
    Scaglia F; Carter S; O'Brien WE; Lee B
    Mol Genet Metab; 2004 Apr; 81 Suppl 1():S79-85. PubMed ID: 15050979
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anesthetic management of patients with ornithine transcarbamylase deficiency.
    Schmidt J; Kroeber S; Irouschek A; Birkholz T; Schroth M; Albrecht S
    Paediatr Anaesth; 2006 Mar; 16(3):333-7. PubMed ID: 16490102
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fatal initial adult-onset presentation of urea cycle defect.
    Lien J; Nyhan WL; Barshop BA
    Arch Neurol; 2007 Dec; 64(12):1777-9. PubMed ID: 18071043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.